Abstract: The present invention relates to lactic acid bacterial strains which are capable of producing or inducing the production of melatonin, for use in the production of melatonin in a subject. Preferred strains for such uses are capable of producing or inducing the production of adenosine. Therapeutic uses of such strains include the treatment or prevention of diseases associated with melatonin deficiency, for example infantile colic. Novel strains are also provided.

Abstract: A computer-implemented method is provided for creating a three-dimensional virtual model of an environment (2) of a motor vehicle (1). The method includes capturing images of the environment (2); determining a plurality of regions (3; 4; 5; 6; 7; 8; 9) in each of the images and calculating a region entropy for each of the regions (3; 4; 5; 6; 7; 8; 9). The method then proceeds by selecting at least one region (4; 9) that has a higher region entropy than other regions (3; 5; 6; 7; 8); and generating the three-dimensional virtual model by first ascertaining three-dimensional coordinates for the selected at least one region (4; 9) and only thereafter ascertaining three-dimensional coordinates for the unselected regions (3; 5; 6; 7; 8). The three-dimensional virtual model includes the three-dimensional coordinates of all regions (3; 4; 5; 6; 7; 8; 9).

Abstract: A method for dynamically adjusting a volume level in an online meeting. The method includes step a. holding an online meeting in which participants can have a conversation with one another. In step b. using an AI algorithm, monitoring and recognizing content of a conversation of the participants in the online meeting and assigning content scores to the content, wherein each participant portion of the participants is assigned a recognized sub-content in the conversation based on the content scores. In step c. using the AI algorithm, recognizing a first intersection of content scores from a plurality of sub-contents, and recognizing a second or more intersections of content scores from other multiple sub-contents. In step d. adjusting volume levels of individual participants, by raising or lowering the volume level of a participant portion for such other participants having one or no intersection with the participant portion.

Abstract: The present invention provides lactic acid bacteria (LAB) which have been engineered to express a therapeutic protein capable of promoting resolution of inflammation and/or wound healing for use in treating or preventing therapy-induced enteropathy in a human or animal subject.

Abstract: The invention relates to selection of bacterial strain for use in treating serotonin deficiency and/or a disease related to serotonin deficiency by culturing bacteria of a lactic acid producing bacterial strain, under aerobic conditions, in a culture medium comprising tryptophan. Any serotonin produced by the bacteria of the lactic acid producing bacterial strain in the culture medium is detected and the lactic acid producing bacterial strain is selected as effective in treating serotonin deficiency and/or a disease related to serotonin deficiency in a subject if serotonin is detected in the culture medium.

Abstract: The invention relates to selection of bacterial strain for use in treating serotonin deficiency and/or a disease related to serotonin deficiency by culturing bacteria of a lactic acid producing bacterial strain, under aerobic conditions, in a culture medium comprising tryptophan. Any serotonin produced by the bacteria of the lactic acid producing bacterial strain in the culture medium is detected and the lactic acid producing bacterial strain is selected as effective in treating serotonin deficiency and/or a disease related to serotonin deficiency in a subject if serotonin is detected in the culture medium.

Abstract: The present invention relates to methods of activating live lactic acid bacteria comprising exposing said bacteria to a preparation comprising citrate, wherein said bacteria have the ability to utilize citrate as an external electron acceptor. The present invention further relates to methods to enhance the activity of certain live bacteria in mammals. More specifically the invention relates to improve the wake-up of certain lactic acid bacteria from the freeze-dried state. The present invention also relates to preparations comprising said activated bacteria and therapeutic uses of said activated bacteria.

Abstract: The present invention relates to lactic acid bacterial strains which are capable of producing or inducing the production of melatonin, for use in the production of melatonin in a subject. Preferred strains for such uses are capable of producing or inducing the production of adenosine. Therapeutic uses of such strains include the treatment or prevention of diseases associated with melatonin deficiency, for example infantile colic. Novel strains are also provided.

Abstract: An apparatus (1) serves for the amusement of persons. It has a fixed frame (2), on which a pivoting frame (3) is supported in an articulated manner about an approximately horizontal pivot axis (4). This pivoting frame (3) can be pivoted between an essentially vertical, closed position and a pivoted, exposed position. A net (5) or mesh is retained in the pivoting frame (3), and the person lies thereon in the exposed position. The pivoting frame (3) can be adjusted by means of at least one threaded spindle (8) with a self-locking thread pitch.

Abstract: A computer-implemented method is provided for creating a three-dimensional virtual model of an environment (2) of a motor vehicle (1). The method includes capturing images of the environment (2); determining a plurality of regions (3; 4; 5; 6; 7; 8; 9) in each of the images and calculating a region entropy for each of the regions (3; 4; 5; 6; 7; 8; 9). The method then proceeds by selecting at least one region (4; 9) that has a higher region entropy than other regions (3; 5; 6; 7; 8); and generating the three-dimensional virtual model by first ascertaining three-dimensional coordinates for the selected at least one region (4; 9) and only thereafter ascertaining three-dimensional coordinates for the unselected regions (3; 5; 6; 7; 8). The three-dimensional virtual model includes the three-dimensional coordinates of all regions (3; 4; 5; 6; 7; 8; 9).

Abstract: A method for dynamically adjusting a volume level in an online meeting. The method includes step a. holding an online meeting in which participants can have a conversation with one another. In step b. using an AI algorithm, monitoring and recognizing content of a conversation of the participants in the online meeting and assigning content scores to the content, wherein each participant portion of the participants is assigned a recognized sub-content in the conversation based on the content scores. In step c. using the AI algorithm, recognizing a first intersection of content scores from a plurality of sub-contents, and recognizing a second or more intersections of content scores from other multiple sub-contents. In step d. adjusting volume levels of individual participants, by raising or lowering the volume level of a participant portion for such other participants having one or no intersection with the participant portion.

Abstract: A method to provide therapeutic microvesicles from probiotic bacteria comprises exposing the bacteria to an inducing treatment during culturing to induce production of therapeutic microvesicles by the bacteria. The therapeutic microvesicles may be used in treatment of, for instance, colic, an infant or childhood gastrointestinal disorder or disease, a gastrointestinal pain disorder, a bone loss disease and/or a periodontal disease.

Abstract: The present invention relates to lactic acid bacterial strains which are capable of producing or inducing the production of melatonin, for use in the production of melatonin in a subject. Preferred strains for such uses are capable of producing or inducing the production of adenosine. Therapeutic uses of such strains include the treatment or prevention of diseases associated with melatonin deficiency, for example infantile colic. Novel strains are also provided.

Abstract: A method to provide therapeutic microvesicles from probiotic bacteria comprises exposing the bacteria to an inducing treatment during culturing to induce production of therapeutic microvesicles by the bacteria. The therapeutic microvesicles may be used in treatment of, for instance, colic, an infant or childhood gastrointestinal disorder or disease, a gastrointestinal pain disorder, a bone loss disease and/or a periodontal disease.

Abstract: The invention herein relates generally to enhancing the survival and activity of probiotic Lactobacillus reuteri strains in mammals by pre-conditioning L. reuteri with GOS during cultivation and to a surprisingly high symbiotic effect of such a pre-conditioned probiotic L. reuteri strain when administered together with GOS further added in the composition. The invention therefore comprises methods for cultivating and manufacturing probiotic L. reuteri strains, and preparing products containing such pre-conditioned strains in combination with additional amounts of GOS. In more detail the present invention relates to a probiotic composition comprising a probiotic L. reuteri strain, obtained by a step of growing the bacteria in a medium comprising GOS, and administering the pre-conditioned bacteria together with further GOS in the final product. The inventors have found that such method induces surprisingly high and unexpected symbiotic beneficial effects of the probiotic bacteria in the gastrointestinal tract.

Abstract: An optical sensor system (1) has plural optical lens systems (2a-2n), a single imaging optical sensor (3) and plural light guides (4a-4n) corresponding to the number of optical lens systems (2a-2n). The light guides (4a-4n) extend respectively between the lens systems (2a-2n) and the optical sensor (3). Each of the lens systems (2a-2n) is associated respectively with one of the light guides (4a-4n). A switching apparatus (5) selectively switches between the light guide means (4a-4n).

Abstract: The present invention relates to novel strains of lactic acid bacteria, more specifically, novel strains of Lactobacillus reuteri, capable of utilizing ethanolamine. This characteristic makes it possible for the bacteria to compete for the same substrate as pathogenic ethanolamine-utilizing pathogens, thereby presenting an effective means to combat infections resulting from such pathogenic bacteria. There is also provided a method of selecting further ethanolamine-utilizing lactic acid bacteria, as well as other methods and uses involving said novel strains and other ethanolamine-utilizing lactic acid bacteria.

Abstract: The present invention relates to novel strains of lactic acid bacteria, more specifically, novel strains of Lactobacillus reuteri, capable of utilizing ethanolamine. This characteristic makes it possible for the bacteria to compete for the same substrate as pathogenic ethanolamine-utilizing pathogens, thereby presenting an effective means to combat infections resulting from such pathogenic bacteria. There is also provided a method of selecting further ethanolamine-utilizing lactic acid bacteria, as well as other methods and uses involving said novel strains and other ethanolamine-utilizing lactic acid bacteria.

Abstract: The present invention relates to a probiotic Lactobacillus reuteri strain obtained by growing the bacteria in a medium comprising galacto-oligosaccharides (GOS), so called pre-conditioning. The pre-conditioning method provides boosting effects of the probiotic L. reuteri strain, such as improved mineral absorption, in the gastrointestinal tract. The invention comprises methods for manufacturing and cultivating probiotic Lactobacillus reuteri strains, and products and first and second medical uses of such strains.